3 ms·
Well, not increase the risk of relapse, since clinical trials usually have relapse or time to some sort of negative event as an endpoint to look for. But to ha
by cko 9y ago
Well, not increase the risk of relapse, since clinical trials usually have relapse or time to some sort of negative event as an endpoint to look for.
But to have patients need to take it in steadily increasing doses for life? Yes, that would describe most maintenance medications out there. And encourage patients to have the illusion that “oh, there’s a pill for that” as one of the factors.
While I was a pharmacist at a long term care pharmacy, it was not unusual to see patients on more than 20 meds. Some of the meds are to be taken more than once daily. “Pill burden” is the term we use to describe this.
What I’ve observed is there is a point of no return in any chronic condition where you can’t diet and exercise your way out of it and you’re relegated to higher and higher doses of diabetic or hypertensive meds. For life.